The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...

ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...

Once the nasal spray is absorbed through the membranes in the nose ... However, any new product applied to the skin has the ...

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.

At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...

Danish allergy immunotherapy specialist ALK Abello has entered into a strategic license agreement with US-based ARS ...

When used as directed, eye-whitening drops are safe for most people. "These drops are safe to use infrequently to improve the ...

The U.S. Food and Drug Administration (FDA) has taken a pivotal step in consumer protection by proposing the removal of oral phenylephrine as an active ingredient in over-the-counter ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak sales of around $400 million in anaphylaxis treatment.

Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected ... “ALK is a specialized pharmaceutical company and a global leader in the allergy field, serving ...